Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NAD-dependent protein deacetylase sirtuin 3, mitochondrial (SIRT3) is the primary protein deacetylase located within the mitochondrial matrix, where it serves as a master regulator of metabolic homeostasis [UniProt: Q9NTG7]. It utilizes NAD+ as a co-substrate to remove acetyl groups from various metabolic enzymes, thereby coordinating the tricarboxylic acid (TCA) cycle, fatty acid oxidation, and the urea cycle in response to cellular energy demands [PMID: 21167305]. A critical function of SIRT3 is the regulation of mitochondrial oxidative stress; by deacetylating and activating superoxide dismutase 2 (SOD2), it facilitates the scavenging of reactive oxygen species and protects the cell from oxidative damage [PMID: 21126506]. In human pathology, reduced SIRT3 activity is linked to the development of metabolic syndrome, cardiac hypertrophy, and neurodegenerative conditions like Alzheimer's disease [PMID: 23603399]. Conversely, its role in cancer is dualistic, acting as a tumor suppressor by maintaining genomic stability or as a survival factor for certain established tumors. Therapeutic interest focuses on SIRT3 activators, such as honokiol, to treat age-related metabolic and cardiovascular diseases, while selective inhibitors like 3-TYP are primarily used as research tools to investigate its complex biological roles [PMID: 25605930, PMID: 24513116].
SIRT3 functions as an NAD+-dependent deacetylase that removes acetyl groups from lysine residues of mitochondrial proteins, thereby modulating their enzymatic activity and metabolic flux [PMID: 21167305]. It also exhibits mono-ADP-ribosyltransferase activity. By activating antioxidant enzymes such as superoxide dismutase 2 (SOD2) through deacetylation at K122, SIRT3 reduces mitochondrial reactive oxygen species (ROS) levels [PMID: 21126506].
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NAD-dependent protein deacetylase sirtuin 3, mitochondrial (SIRT3).